Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedAug 19, 2026
DataAggregated Company Financials
Companies44
- 7D-2.9%
- 3M-0.8%
- 1Y-23.8%
- YTD-14.6%
Over the last 7 days, the Pharma industry has dropped 2.9%, driven by a pullback from Hansoh Pharmaceutical Group of 5.6%. On the other hand Sunshine Lake Pharma is actually up 6.2%. However, the industry is down 24% over the past year. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 19 Aug 2026 | HK$687.4b | HK$525.1b | HK$28.2b | 13.6x | 24.4x | 1.3x |
| Fri, 17 Jul 2026 | HK$698.8b | HK$522.6b | HK$28.1b | 14.5x | 24.9x | 1.3x |
| Sun, 14 Jun 2026 | HK$635.3b | HK$522.5b | HK$29.3b | 13.1x | 21.7x | 1.2x |
| Tue, 12 May 2026 | HK$736.1b | HK$520.2b | HK$30.1b | 15x | 24.5x | 1.4x |
| Thu, 09 Apr 2026 | HK$793.5b | HK$516.9b | HK$30.2b | 15.3x | 26.3x | 1.5x |
| Sat, 07 Mar 2026 | HK$762.4b | HK$498.1b | HK$30.4b | 12.4x | 25.1x | 1.5x |
| Mon, 02 Feb 2026 | HK$819.7b | HK$494.1b | HK$30.3b | 13.3x | 27.1x | 1.7x |
| Wed, 31 Dec 2025 | HK$780.6b | HK$489.7b | HK$30.0b | 13x | 26x | 1.6x |
| Fri, 28 Nov 2025 | HK$834.7b | HK$483.3b | HK$30.2b | 13.5x | 27.6x | 1.7x |
| Sun, 26 Oct 2025 | HK$777.6b | HK$480.2b | HK$30.1b | 13.7x | 25.8x | 1.6x |
| Tue, 23 Sep 2025 | HK$802.9b | HK$479.5b | HK$30.6b | 13.8x | 26.2x | 1.7x |
| Thu, 21 Aug 2025 | HK$783.2b | HK$477.2b | HK$31.2b | 11.9x | 25.1x | 1.6x |
| Sat, 19 Jul 2025 | HK$740.2b | HK$475.3b | HK$29.1b | 12.7x | 25.5x | 1.6x |
| Mon, 16 Jun 2025 | HK$666.8b | HK$476.7b | HK$28.8b | 11.5x | 23.1x | 1.4x |
| Wed, 14 May 2025 | HK$496.4b | HK$474.4b | HK$29.0b | 10.9x | 17.1x | 1x |
| Fri, 11 Apr 2025 | HK$461.5b | HK$464.6b | HK$28.5b | 9.6x | 16.2x | 1x |
| Sun, 09 Mar 2025 | HK$452.3b | HK$464.2b | HK$31.9b | 8.6x | 14.2x | 1x |
| Tue, 04 Feb 2025 | HK$410.1b | HK$464.7b | HK$32.0b | 8.4x | 12.8x | 0.9x |
| Thu, 02 Jan 2025 | HK$433.4b | HK$460.1b | HK$31.7b | 8.6x | 13.7x | 0.9x |
| Sat, 30 Nov 2024 | HK$444.3b | HK$463.1b | HK$31.5b | 8.1x | 14.1x | 1x |
| Mon, 28 Oct 2024 | HK$482.4b | HK$470.9b | HK$32.7b | 7.9x | 14.7x | 1x |
| Wed, 25 Sep 2024 | HK$449.4b | HK$477.4b | HK$33.1b | 7.7x | 13.6x | 0.9x |
| Fri, 23 Aug 2024 | HK$430.9b | HK$464.8b | HK$30.7b | 6.9x | 14x | 0.9x |
| Sun, 21 Jul 2024 | HK$430.5b | HK$457.8b | HK$32.5b | 7.5x | 13.2x | 0.9x |
| Tue, 18 Jun 2024 | HK$461.6b | HK$463.1b | HK$33.9b | 8.3x | 13.6x | 1x |
| Thu, 16 May 2024 | HK$488.4b | HK$464.0b | HK$33.8b | 8.9x | 14.5x | 1.1x |
| Sat, 13 Apr 2024 | HK$440.7b | HK$464.9b | HK$33.8b | 7.6x | 13x | 0.9x |
| Mon, 11 Mar 2024 | HK$439.1b | HK$470.9b | HK$33.5b | 8x | 13.1x | 0.9x |
| Wed, 07 Feb 2024 | HK$418.0b | HK$473.1b | HK$33.9b | 6.7x | 12.3x | 0.9x |
| Fri, 05 Jan 2024 | HK$489.9b | HK$472.2b | HK$33.7b | 8.2x | 14.5x | 1x |
| Sun, 03 Dec 2023 | HK$506.1b | HK$472.6b | HK$33.8b | 7.5x | 15x | 1.1x |
| Tue, 31 Oct 2023 | HK$483.0b | HK$469.0b | HK$31.5b | 6.7x | 15.3x | 1x |
| Thu, 28 Sep 2023 | HK$438.8b | HK$469.1b | HK$31.5b | 6.8x | 13.9x | 0.9x |
| Sat, 26 Aug 2023 | HK$424.2b | HK$448.9b | HK$30.7b | 7.8x | 13.8x | 0.9x |
Price to Earnings Ratio
13.8x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 24.4x which is higher than its 3-year average PE of 18.6x.
- The industry is trading close to its 3-year average PS ratio of 1.2x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 2.8% per year over the last three years.
- Meanwhile revenues for these companies have grown 5.4% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 0.02% | |
| Healthcare | -1.29% | |
| Pharma | -2.90% | |
| Pharma | -2.90% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2637 Fujian Haixi Pharmaceuticals | HK$200.00 | 1.6% +HK$251.9m | n/a | PE76.4x | |
| 6887 Sunshine Lake Pharma | HK$37.20 | 0.9% +HK$184.3m | -30.1% | PE67.6x | |
| 2652 CF PharmTech | HK$16.40 | 1.8% +HK$119.1m | n/a | PE2329.2x | |
| 1093 CSPC Pharmaceutical Group | HK$8.69 | 0.1% +HK$114.3m | -16.1% | PE26.2x | |
| 950 Lee's Pharmaceutical Holdings | HK$1.16 | 8.4% +HK$53.0m | -38.3% | PE7.4x |